Octagam 10% Infusion Rate Calculator
Clinical Titration Tool for Healthcare Professionals
Quick Presets (Standard Titration):
Calculation Results:
*Note: This calculation is based on Octagam 10% (100mg/mL) concentration.
Understanding Octagam 10% Infusion Rates
Octagam 10% [Immune Globulin Intravenous (Human)] is a high-concentration 10% liquid preparation of highly purified immunoglobulin G (IgG). Accurate infusion rate calculation is critical for patient safety, particularly during the initial titration phase to mitigate potential adverse reactions.
Standard Titration Protocol
The concentration of Octagam 10 is 100 mg per mL. Clinical guidelines typically recommend the following titration schedule for patients with Primary Humoral Immunodeficiency (PI):
| Stage | Rate (mg/kg/min) | Duration |
|---|---|---|
| Initial Rate | 1.0 mg/kg/min | First 30 minutes |
| Maintenance | Up to 8.0 mg/kg/min | As tolerated |
How to Calculate mL/hr for Octagam 10%
To convert the prescribed dosage from mg/kg/min to the pump setting (mL/hr), use the following clinical formula:
Example Calculation
For a patient weighing 80 kg, starting at the initial rate of 1.0 mg/kg/min:
- Step 1: Calculate mg per minute: 80 kg × 1.0 mg/kg/min = 80 mg/min.
- Step 2: Convert mg/min to mL/min: 80 mg/min ÷ 100 mg/mL = 0.8 mL/min.
- Step 3: Convert to hourly rate: 0.8 mL/min × 60 min = 48 mL/hr.
Important Clinical Considerations
- Hydration: Ensure patients are adequately hydrated prior to starting the infusion.
- Renal Function: For patients at risk of renal dysfunction, infuse at the minimum rate practicable.
- Monitoring: Assess vital signs throughout the infusion, especially when increasing the rate.
- Maximum Rate: Do not exceed the maximum infusion rate of 0.12 mL/kg/min (12 mg/kg/min) for PI patients as specified in the product labeling.
Disclaimer: This calculator is for educational purposes only and should not replace clinical judgment. Always refer to the official Octagam 10% prescribing information and institutional protocols for dosing and administration guidelines.